Pacific Biosciences of California PACB Operating Income
Discontinued — last reported Q1 '26
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's operating income?
- Pacific Biosciences of California (PACB) reported operating income of -$8.36M in Q1 2026.
- How has Pacific Biosciences of California's operating income changed year-over-year?
- Pacific Biosciences of California's operating income increased by 98.1% year-over-year, from -$428.93M to -$8.36M.
- What is the long-term trend for Pacific Biosciences of California's operating income?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's operating income has grown at a 27.4% compound annual growth rate (CAGR), from -$210.44M to -$553.86M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.